News

Gentle Technologies Event

We are thrilled to share the resounding success of our recent event, a collaboration that brought together three pioneering startup companies Trince, LiveDrope and Aenitis technologies at the forefront of Gentle Technologies for Cell Processing. This exclusive gathering showcased groundbreaking innovations that are shaping the future of cell processing and advancing the boundaries of biotechnology The success of this event reaffirms our commitment to promoting innovation in biotechnology. As we continue to explore the limitless possibilities of Gentle Technologies for Cell Processing, we look forward to playing a pivotal role in shaping the future of

Lire la suite »

ESGCT, Brussels

DATE: Tuesday, October 24, 2023 – Friday, October 27, 2023 LOCATION: Brussels, Belgium The European Society of Gene and Cell Therapy Annual Congress brings together a stellar lineup of over 100 eminent experts who share their most recent research findings and breakthroughs. This distinguished gathering includes Nobel Prize recipients and scientists on the forefront of the field, making ESGCT a platform for exploring the most exciting topics and revolutionary research in the domain of cell and gene therapy. Our sponsorship at ESGCT represents a significant milestone in our journey to redefine the landscape of cell

Lire la suite »

ISCT Annual Meeting 2023 and Aenitis Technologies side event

The ISCT (International Society for Cell and Gene Therapy) conference is a renowned annual event that serves as a global gathering point for scientists, researchers, clinicians, and industry professionals in the field of cell and gene therapy. This conference offers a unique platform for the exchange of groundbreaking ideas, the presentation of cutting-edge research, and the discussion of the latest advancements in the rapidly evolving realm of regenerative medicine. At the conference, our team had the privilege to engage with leading experts, researchers, and industry pioneers who are shaping the future of cell therapy. The

Lire la suite »

 Contactless platelets isolation using acoustic radiation force 

The isolation of platelets from platelet-rich plasma (PRP) is a critical step in various medical applications, including tissue engineering, wound healing, and regenerative medicine. The use of acoustic forces to separate platelets from PRP offers a non-invasive and efficient approach to achieving this goal. Acoustic radiation forces mobilize cells in flow according to their volume and density without contact and pressure.

Lire la suite »

Novel method to enhance T-lymphocyte viral transduction by acoustophoresis

Gene editing using lentiviral vectors has become a compelling and safe method in cellular therapy specifically for T-cells through the expression of a chimeric antigen receptor. However, the efficiency of the gene transfer to the T-cells has remained a burden. Another limitation of this very approach is that these viral vectors are hard to provide, thus expensive and conventional transduction methods exhibit a high multiplicity of infection, i.e. the viral vectors are used in large excesses compared to cells.  Therefore, we developed an acoustophoresis system to enhance the transduction efficiency of T-lymphocytes using minimum viral particles to

Lire la suite »

Low mechanical stress and high throughput concentration of

cells with acoustophoresis Acoustophoresis is an ultrasound based technique to replace most cell sorting and washing devices such as centrifuges. It uses low acoustic radiation forces to make cells migrate to a pressure node. Unlike a centrifuge, Aenitis’ technology works completely in flow and can be part of a more complex fluidic system. It can be used to sort, wash and concentrate all kinds of cells and tissues, with no change in cell viability. Flow rates can range from 0.5 ml/min to 40 ml/min. Previous results have shown that acoustophoresis can be used safely on

Lire la suite »

Characterization of the acoustic contrast factor: a new approachfor a label-free separation of the stromal vascular fraction

Acoustophoresis is an emerging technology allowing cell separation based on their physical properties via ultrasound. The compressibility and density of the cell and its surrounding mediumdefine an acoustic contrast factor (ACF), which governs the migration direction of the cell. Different cell types with distinct ACFs would be separable by acoustophoresis. This innovative methodhas the advantages to be non-contact, label-free, and working in a controlled flow. Those features make it a promising solution for any bioproduction process requiring isolation and processingof cells without the disadvantages of centrifugation or immunomagnetic separation. It has already been successfully used

Lire la suite »

Aenitis Technologies Receives €4M in Funding from the European H2020 / SME Instrument Programme, for Its ABC-S’ Project (Acoustic Blood Cell Sorter)

“This funding will help to accelerate the roll-out of acoustic blood cell sorting technology to industrial scale”‍ Aenitis Technologies, which develops new medical equipment based on acoustic manipulation of biological particles, today announced that it has received €4 million in funding, following its application to the highly-selective SME Instrument Phase 2 European programme, in the “Healthcare Biotechnology” category. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171130005528/en/ SME Instrument Phase 2 is part of Horizon 2020, a programme managed by the European Commission and dedicated to innovation and research. It is part of the Industrial

Lire la suite »

La DGA s’allie à Aenitis Technologies en thérapie cellulaire

Spin-off du CNRS et de l’ESPCI Paris, Aenitis Technologies développe des dispositifs médicaux de manipulation et de tri cellulaires basés sur l’utilisation de l’énergie acoustique. Ce mercredi, la société annonce la signature d’un partenariat avec la Direction générale de l’armement (DGA) pour mettre au point un nouveau processus de préparation des cellules stromales mésenchymateuses (CSM), les plus utilisées en médecine régénérative. En plein essor, la thérapie cellulaire génère des candidats médicaments prometteurs, mais se confronte à des difficultés de bioproduction. Pour les pallier, Aenitis Technologies développe des dispositifs médicaux de manipulation et de tri cellulaires basés sur

Lire la suite »

Industrie Pharma : Aenitis à l’écoute pour optimiser la séparation

Une approche innovante pour optimiser les processus de bioproduction, via l’utilisation de la force acoustique, c’est ce que propose la start-up parisienne, hébergée au sein de l’hôpital Saint-Louis, Aenitis Technologies.  ‍ Focus sur les quatre segments dans lesquels la jeune entreprise compte bien faire son chemin. ‍ Acoustophorèse ou lévitation acoustique, telle est le nom de la méthode utilisée par la start-up Aenitis Technologies pour séparer, manipuler et filtrer des particules biologiques. Implantée à l’hôpital Saint-Louis de Paris, « pour disposer de l’expertise en thérapie cellulaire et de tout le matériel biologique nécessaire », comme

Lire la suite »